vialroom

#dosing-titration 2025-01-05

Sunday23 messages6 participantstimes are UTC
Highlights from this day
  • ms_ms_mira — is it normal for appetite to come back at the end of the week 21:05
  • triple_ag_tom — holding is not failing. most people here who lasted two years held at least one dose for months 21:43
  • triple_ag_tom — split dosing has no trial behind it. people here do it and report on it, thats all 21:47
  • VialBot — Verification log updated: SSA — evidence added, status unchanged. 22:41
MM

ok so does a missed week reset anything or do you just carry on

MM

update on the earlier thing update from 4 months ago: held at the same dose the whole time and still losing slowly

the trials escalated on a fixed schedule because a trial has to. you are not a trial

MM

is it normal for appetite to come back at the end of the week

Trial scheduleWhat most people here do
Step interval4 weeks, fixed4-12 weeks, on symptoms
Holdingprotocol deviationnormal and expected
Top dosereached by designoften never reached
Coming downnot studiedcommon at maintenance
VB

Testing queue: 4 submissions open, 54 awaiting dispatch.

ST

appetite returning at the end of the week is extremely common and is not the dose failing

TA

whats the smallest step anyone has managed between doses

Cited study
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)
New England Journal of Medicine · 2021
68 weeks, semaglutide 2.4mg weekly against placebo, with lifestyle intervention in both arms.

has anyone gone up and then straight back down and been glad they tried
if you are going up because the scale stalled for two weeks, wait. two weeks is noise

TA

coming back to this with a roughly seven day half-life you are near steady state after about five weeks at a dose

holding is not failing. most people here who lasted two years held at least one dose for months

🧪1⚠️12

if the current dose is still working, going up is spending headroom you might want later

[edited]

i jumped a rung once to catch up after a supply gap and it was a bad week. would not repeat

split dosing has no trial behind it. people here do it and report on it, thats all

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.
💀5🧪9
ST

i drifted from sunday to wednesday over a year and only noticed when i checked the log

FT

if i took it 6 days late do i shift the schedule or go back to the old day

i went to the top of the ladder, felt no better than two rungs down, and came back. that is data for me and nobody else

ST

if it "stopped working after four days" that is almost never pharmacokinetics

no trial for that

hold

MM

the ladder in the trials is a starting point, not a schedule you owe anyone

VB

Verification log updated: SSA — evidence added, status unchanged.